GuidelineHNO2026
[Current indications for cochlear implantation].
Guideline in HNO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The indications for treatment with a cochlear implant (CI) have steadily expanded over the years. While the CI was originally designed for deaf adults, the range of indications now also includes patients with profound uni- or bilateral sensorineural hearing loss, unilateral deafness, or residual hearing. Infants and toddlers are also fitted, preferably before the age of 1 year, in order to create optimal conditions for language development. New developments such as gene therapy for otoferlin mutations or CI treatment for vestibular schwannomas further expand the treatment options. The indication is determined individually for each ear, taking audiological, imaging, psychosocial, and cognitive factors into account. The current S2k guideline of the Association of the Scientific Medical Societies in Germany (AWMF) aims to promote high-quality care and emphasizes the importance of interprofessional collaboration in the diagnostic and care process.
Indexed as
Identifiers
41718821What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.